Systems-level Identification of <i>Tinospora cordifolia</i> Constituents as CXCR4-targeting Anti-metastatic Agents

Background: Metastasis is the leading cause of cancer-related mortality and is regulated by complex processes, including epithelial-mesenchymal transition, invasion, and colonisation. The chemokine receptor CXCR4, interacting with its ligand CXCL12, plays a pivotal role in tumour progression and organ-specific metastasis. Current synthetic CXCR4 inhibitors, such as AMD3100, face limitations due to toxicity, cost, and resistance, highlighting the need for safer alternatives. T. cordifolia, a medicinal plant rich in bioactive phytochemicals, has demonstrated immunomodulatory and anticancer properties but remains unexplored in CXCR4-targeted anti-metastatic therapy. Aim: This study aimed to investigate the anti-metastatic potential of eighteen phytochemicals from Tinospora cordifolia against CXCR4 (PDB ID: 3ODU) using integrated in silico and in vitro approaches. Methods: Phytochemicals were retrieved from the IMPPAT database, and Protein-Protein Interaction (PPI) analysis was performed using STRING to validate the role of CXCR4 in metastasis. Molecular docking (AutoDock Vina) evaluated ligand-receptor interactions. Drug-likeness was assessed via Lipinski's Rule of Five, and pharmacokinetic profiling was carried out using ADME predictors. Cytotoxicity was evaluated by MTT assay against CXCR4-positive MDA-MB-231 and HEK293 cells. Results: MTT assays revealed a non-toxic window up to 10 µM for all compounds, with tumour-selective effects of kaempferol and ?-sitosterol at higher concentrations. Docking scores ranged from -6.5 to -9.5 kcal/mol, with beta-sitosterol (-9.5 kcal/mol), tinosporaside (-9.1 kcal/mol), and malabarolide (-8.7 kcal/mol) showing the strongest interactions, stabilising via hydrophobic and hydrogen bonding with key CXCR4 residues. Fourteen compounds met drug-likeness criteria, and seven lead molecules demonstrated optimal ADME properties, including non-BBB permeability, high GI absorption, and minimal CYP450 interactions. The seven identified lead com

View article page

Download PDF